Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC.

ABSTRACT:

Introduction

Patients with early NSCLC (eNSCLC) who experience recurrence are associated with worse survival outcomes, but the economic burden of recurrence is not well characterized. This study evaluated the incremental health care resource utilization and costs of recurrence in Medicare patients with resected eNSCLC.

Methods

This retrospective observational study used Surveillance, Epidemiology, and End Results cancer registry data linked with Medicare claims. Eligible patients were 65 years and older with newly diagnosed NSCLC stages IB to IIIA (American Joint Committee on Cancer Staging Manual, seventh edition) and surgery between January 2010 and December 2017. Continuous enrollment criteria were applied to ensure appropriate data capture. Per patient per month (PPPM) h

SUBMITTER: Lee JM 

PROVIDER: S-EPMC10050774 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature